HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaru Takeuchi Selected Research

Hemorrhage

11/2023Ischemic Retinopathy with Vitreous Hemorrhage Resembling Diabetic Retinopathy in a Patient with Mixed Cryoglobulinemia.
11/2022A New Pharmacological Vitreolysis through the Supplement of Mixed Fruit Enzymes for Patients with Ocular Floaters or Vitreous Hemorrhage-Induced Floaters.
10/2021Sub internal limiting membrane hemorrhage followed by bilateral optic disc hemorrhage in Kikuchi-Fujimoto disease: a case report.
1/2012Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab.
11/2005Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaru Takeuchi Research Topics

Disease

33Uveitis
09/2023 - 09/2002
29Inflammation (Inflammations)
09/2023 - 02/2003
12Diabetic Retinopathy (Retinopathy, Diabetic)
11/2023 - 02/2010
9Sarcoidosis (Schaumann Disease)
01/2020 - 03/2006
7Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
12/2023 - 06/2008
7Retinal Detachment (Retinal Detachments)
05/2023 - 04/2010
7Cataract (Cataracts)
01/2022 - 01/2014
7Macular Edema
01/2022 - 04/2011
7Acute Retinal Necrosis Syndrome
01/2021 - 09/2002
6Macular Degeneration (Age-Related Maculopathy)
10/2023 - 09/2014
6Behcet Syndrome (Behcet's Syndrome)
01/2023 - 10/2006
6Endophthalmitis (Ophthalmia)
10/2022 - 09/2013
5Hemorrhage
11/2023 - 11/2005
5Hypertension (High Blood Pressure)
06/2020 - 05/2009
4Vitreous Hemorrhage
11/2022 - 01/2017
4Retinal Perforations
03/2022 - 12/2003
4Glaucoma
01/2022 - 09/2009
4Anterior Uveitis
01/2018 - 09/2002
3Infections
11/2023 - 01/2018
3Blindness (Hysterical Blindness)
09/2023 - 12/2007
3Vision Disorders (Hemeralopia)
09/2023 - 04/2020
3Ocular Hypertension (Glaucoma, Suspect)
01/2020 - 01/2017
3Neovascular Glaucoma
10/2019 - 01/2018
3Retinal Vasculitis
07/2017 - 11/2005
3Delayed Hypersensitivity (Hypersensitivity, Type IV)
08/2004 - 06/2002
2Autoimmune Diseases (Autoimmune Disease)
12/2023 - 01/2002
2Ischemia
11/2023 - 01/2018
2Polypoidal Choroidal Vasculopathy
10/2023 - 03/2023
2COVID-19
09/2022 - 01/2022
2Panuveitis
01/2022 - 03/2019
2Neoplasms (Cancer)
01/2021 - 10/2010
2Hypoxia (Hypoxemia)
01/2021 - 01/2019
2Retinitis
08/2018 - 06/2013
2Phototoxic Dermatitis (Phototoxicity)
01/2018 - 10/2012
2Carcinoma (Carcinomatosis)
12/2017 - 04/2005
2Retinal Vein Occlusion
01/2017 - 04/2011
2Phlebitis
01/2017 - 07/2013
2Iridocyclitis
01/2015 - 11/2005
2Vitreous Detachment (Posterior Vitreous Detachment)
11/2012 - 04/2010
2Choroidal Neovascularization
01/2012 - 07/2009
2Hypersensitivity (Allergy)
04/2009 - 02/2007

Drug/Important Bio-Agent (IBA)

21Retinaldehyde (Retinal)IBA
11/2023 - 11/2005
17CytokinesIBA
12/2023 - 01/2006
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 07/2009
13Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 01/2013
8Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2023 - 01/2012
7Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2002
7AntigensIBA
02/2017 - 06/2002
6Infliximab (Remicade)FDA Link
01/2023 - 08/2013
6Interleukin-17 (Interleukin 17)IBA
01/2020 - 06/2010
5Fluorescein (Funduscein)FDA LinkGeneric
05/2023 - 01/2012
5Interleukin-6 (Interleukin 6)IBA
01/2018 - 06/2010
5SteroidsIBA
02/2017 - 10/2012
5Interferon-gamma (Interferon, gamma)IBA
09/2014 - 03/2006
4Adalimumab (Humira)FDA Link
09/2023 - 04/2020
4InterferonsIBA
01/2021 - 02/2010
4Interleukin-10 (Interleukin 10)IBA
01/2020 - 10/2010
4ChemokinesIBA
01/2020 - 02/2003
4Interleukin-4 (Interleukin 4)IBA
02/2017 - 01/2006
4Interleukin-8 (Interleukin 8)IBA
10/2011 - 01/2008
4AutoantigensIBA
06/2010 - 01/2006
3Coloring Agents (Dyes)IBA
02/2023 - 11/2014
3AntibodiesIBA
09/2022 - 06/2002
3Messenger RNA (mRNA)IBA
09/2022 - 01/2021
3Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2020
3Interleukin-22 (IL-22)IBA
01/2020 - 01/2015
3Ophthalmic Solutions (Eye Drops)IBA
03/2019 - 01/2015
3Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
03/2019 - 12/2003
3Immunosuppressive Agents (Immunosuppressants)IBA
08/2018 - 01/2013
3Latanoprost (Xalatan)FDA Link
07/2017 - 09/2013
3Tuberculin (PPD)IBA
01/2017 - 09/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 06/2013
2Immunoglobulin G (IgG)IBA
11/2023 - 03/2006
2EnzymesIBA
11/2022 - 06/2008
2BNT162 VaccineIBA
09/2022 - 01/2022
2COVID-19 VaccinesIBA
09/2022 - 01/2022
2VaccinesIBA
01/2022 - 10/2010
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022 - 04/2020
2afliberceptIBA
01/2021 - 12/2020
2Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 01/2014
2Antiglaucoma AgentsIBA
01/2018 - 01/2017
2Retinal Pigments (Pigments, Visual)IBA
01/2018 - 10/2012
2Timolol (Blocadren)FDA LinkGeneric
02/2017 - 09/2013
2Travoprost (Travatan)FDA Link
02/2017 - 09/2013
2Ranibizumab (Lucentis)FDA Link
01/2017 - 01/2012
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2011 - 02/2010
2Peptides (Polypeptides)IBA
04/2009 - 08/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2008 - 01/2006
1GlucocorticoidsIBA
12/2023
1Immunoglobulin M (IgM)IBA
11/2023
1CryoglobulinsIBA
11/2023

Therapy/Procedure

23Vitrectomy
11/2023 - 12/2003
19Therapeutics
12/2023 - 11/2010
5Aftercare (After-Treatment)
09/2023 - 11/2014
5Intravitreal Injections
12/2020 - 02/2007
4Operative Surgical Procedures
06/2020 - 08/2019
4Light Coagulation
06/2020 - 07/2013
2Transplantation
08/2022 - 12/2007
2Slit Lamp
12/2018 - 02/2007
2Immunotherapy
03/2012 - 04/2009